Troy Brady
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
Papers in
-
- CRISPR and Genetic Engineering 8
- RNA and protein synthesis mechanisms 3
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- Frederic D. Bushman (13 shared papers)Nirav Malani (10 shared papers)Charles C. Berry (5 shared papers)Shoshannah L. Roth (4 shared papers)Torsten Schaller (2 shared papers)Leo C. James (2 shared papers)Karen E. Ocwieja (2 shared papers)Greg J. Towers (2 shared papers)
- Journals
- PLoS Pathogens (3 papers)Molecular Cell (1 paper)Journal of Histochemistry & Cytochemistry (1 paper)Nucleic Acids Research (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Troy Brady
17 papers receiving 1.9k citations
Troy Brady's Hit Papers
Peers
Comparison fields: 5 of 76
- Virology 760
- Infectious Diseases 439
- Oncology 482
- Genetics 516
- Immunology 351
Countries citing papers authored by Troy Brady
This map shows the geographic impact of Troy Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy Brady more than expected).
Fields of papers citing papers by Troy Brady
This network shows the impact of papers produced by Troy Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy Brady. The network helps show where Troy Brady may publish in the future.
Co-authors
The 25 scholars most cited alongside Troy Brady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells Hit paper breakdown → | 2012 | 503 |
| 2 | 2011 | 379 | |
| 3 | 2011 | 177 | |
| 4 | 2013 | 157 | |
| 5 | 2009 | 121 | |
| 6 | 2012 | 115 | |
| 7 | 2009 | 89 | |
| 8 | 2014 | 68 | |
| 9 | 2007 | 57 | |
| 10 | 2011 | 56 | |
| 11 | 2011 | 55 | |
| 12 | 2013 | 37 | |
| 13 | 2008 | 36 | |
| 14 | 2013 | 22 | |
| 15 | 2008 | 18 | |
| 16 | 2007 | 14 | |
| 17 | 1988 | 2 |
About Troy Brady
Troy Brady is a scholar working on Molecular Biology, Virology, Genetics, Plant Science and Infectious Diseases, having authored 17 papers that have together received 1.9k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (8 papers), HIV Research and Treatment (6 papers), Chromosomal and Genetic Variations (5 papers), Virus-based gene therapy research (5 papers), RNA and protein synthesis mechanisms (3 papers), Viral gastroenteritis research and epidemiology (2 papers), HIV/AIDS drug development and treatment (2 papers) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Virology (760 citations), Infectious Diseases (439 citations), Oncology (482 citations), Genetics (516 citations) and Immunology (351 citations). Troy Brady has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Frederic D. Bushman, Nirav Malani, Charles C. Berry, Shoshannah L. Roth, Torsten Schaller, Leo C. James, Karen E. Ocwieja, Greg J. Towers, Luis M. Agosto and Una O’Doherty. Their work appears in journals such as PLoS Pathogens, Molecular Cell, Journal of Histochemistry & Cytochemistry, Nucleic Acids Research and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.